Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (1241)	12/22/1997 1:20:00 PM
From: Rick Slemmer	Read Replies (1) \| Respond to of 7041

Good; I am pleased to hear that you haven't mortgaged the house on ZONA and that you are well diversified. That being said, I suppose we have to agree to disagree on ZONA's future. Time will tell which of us (if either) is correct. If you understand the market and technology of Zonagen's product line, you have an edge over me, and for the time being, I will yield to your background. Happy holidays! RS

To: Dauntless who wrote (1241)	12/22/1997 6:36:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 7041

Dauntless <<If Zonagen files their NDA before the FDA responds to PFE's then they will be granted expedited review (6 months) - just like PFE.>> Daunt: This scenario is what Zonagen's CEO hopes will happen. Unfortunately for ZONAers, even if the NDA deadline is met, the FDA still may or may not give the Vasomax NDA an expedited review. BigKNY3